Breast Cancer Clinical Trial

Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study

Summary

This research study is evaluating ear acupuncture as a possible treatment to reduce symptoms related to receiving chemotherapy.

View Full Description

Full Description

Chemotherapy drugs used to treat cancer can cause many symptoms. Some of the most common symptoms of receiving chemotherapy are nausea, vomiting, and anxiety. These symptoms can affect the quality of life of cancer patients. Medications can help ease these, but many patients continue to experience symptoms despite these treatments.

Acupuncture has been studied in clinical trials in cancer patients and has been shown to be helpful for management of pain, nerve damage from chemotherapy, and nausea.

Ear acupuncture is a type of acupuncture that involves the stimulation of points on the external ear. A few studies have suggested that ear acupuncture may help to reduce symptoms of nausea and anxiety during chemotherapy.

This study is being done to evaluate the potential benefits of using ear acupuncture to reduce symptoms like nausea and anxiety for women receiving chemotherapy for breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

History of histologically or cytologically proven Stage I-III breast cancer receiving intravenous chemotherapy on an every 14 days or every 21 days schedule
Age ≥ 18 years
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Signed informed consent

Exclusion Criteria:

Receiving weekly chemotherapy
Unstable cardiac disease or myocardial infarction within 6 months prior to study entry
Uncontrolled seizure disorder
Pregnancy or potential pregnancy
Active clinically significant uncontrolled infection
Prior use of acupuncture within 3 months prior to the study entry
Uncontrolled major psychiatric disorders, such as major depression or psychosis
Metastatic breast or other cancer

Study is for people with:

Breast Cancer

Estimated Enrollment:

26

Study ID:

NCT03170648

Recruitment Status:

Active, not recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

26

Study ID:

NCT03170648

Recruitment Status:

Active, not recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider